Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy

Diabetes Care

Volumn 22, Issue 10, 1999, Pages 1607-1611

  Heller, Simon R ^a,d   Amiel, Stephanie A ^b   Mansell, Peter ^c  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; RISK BENEFIT ANALYSIS;

ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RISK FACTORS;

EID: 0032861268     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.10.1607     Document Type: Article

References (24)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Reichard P, Nilsson B-Y, Rosenquist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
3. Diabetes Control and Complications Trial Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450-459, 1991
4. Cryer PE: Hypoglycemia unawareness in IDDM. Diabetes Care 16:40-47, 1994
5. Binder C, Lauritzen T, Faber O, Pramming S: Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984
6. Dimitriadis G, Gerich JE: Importance of timing of pre-prandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1985
7. Zinman B: The physiologic replacement of insulin: an elusive goal. N Engl J Med 321: 363-370, 1989
8. Brange J, Owens DR, Kang S, Voland A: Monomeric insulins and their experimental and clinical implications. Diabetes Care 13:923-954, 1990
9. DiMarchi RD, Chance RE, Long HB, Shields JE, Slieker LJ: Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor-I. Horm Res 41 (Suppl. 2):93-96, 1994
10. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]- human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
11. Tuominen JA, Karonen S-L, Melamies L, Bolli GB, Koivisto VA: Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia 38:106-111, 1995
12. Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Strarke AAR, Berger M: Prandial glycaemia after a carbohydrate- rich meal in type 1 diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Diabet Med 13:625-629, 1996
13. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, DiVincenzo A, Epifano L, Ciofetta M, Pampanelli S, Brunetti P, Bolli GB: Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994
14. Pfützner A, Küstner E, Forst T, Schulze-Scleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 104: 25-30, 1996
15. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group. Diabetes 46:265-270, 1997
16. Torlone E, Pampanelli S, Lalli C, Del Sindaco P, DiVincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli GB: Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on post-prandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
17. Garg SK, Carmain JA, Braddy KC, Anderson JH Jr, Vignati L, Jennings MK, Chase HP: Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 13:47-52, 1996
18. Altman DG: Clinical trials. In Practical Statistics for Medical Research. London, Chapman & Hall, 1991, p. 440-474
19. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in non-diabetic humans. Diabetes 40:223-226, 1991
20. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect of intensive insulin therapy on glycemic thresholds for counter-regulatory hormone release. Diabetes 37: 901-907, 1988
21. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, DiVincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellti F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds of most neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short- term IDDM. Diabetes 42:1683-1689, 1993
22. Cranston I, Lomas J, Maran A, Macdonald IA, Amiel SA: Restoration of hypoglycaemia unawareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283-287, 1994
23. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH Jr, for the Benelux-UK Insulin Lispro Study Group: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. Diabetes Care 20:1827-1832, 1997
24. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, Service FJ: Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion and intensified conventional insulin therapy. N Engl J Med 303:1313-1318, 1980